Printer Friendly
The Free Library
14,559,005 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ADVISORY/Potential Cure for Type 1 Diabetes to be Demonstrated by Physicians At University of Illinois At Chicago Medical Center.


Business Editors/Medical Writers

ADVISORY...for Wednesday Wednesday: see week.  (May 16)

--(BUSINESS WIRE)

Cell Isolation Facility Used for New Procedure is the Only One

of Its Kind in Illinois Illinois, river, United States
Illinois, river, 273 mi (439 km) long, formed by the confluence of the Des Plaines and Kankakee rivers, NE Ill., and flowing SW to the Mississippi at Grafton, Ill. It is an important commercial and recreational waterway.
 


      Note:    Excellent visuals of leading-edge medical technology and
             interviews with physicians leading the program.

      What:    The University of Illinois at Chicago Medical Center will
             be giving a tour to media, physicians and other guests of
             a leading-edge, "Class 100" cell isolation facility used

             for a promising new clinical procedure with the goal of
             curing Type 1 diabetes. The procedure may eliminate the
             need for insulin and the long-term complications of
             diabetes for millions of people.

      Who:     Program leaders Cristiana Rastellini, M.D., and Enrico
             Benedetti, M.D. Drs. Rastellini and Benedetti will both
             be present at the tour and available to discuss this
             program, supported by the National Institutes of Health.

      When:    Wednesday, May 16, 2001. The tour begins at 5:30 p.m.,
             following a Continuing Medical Education (CME) event on
             islet cell transplantation that begins at 2 p.m. The
             event coincides with the American Society of
             Transplantation and the American Society of Transplant
             Surgeon's joint Transplant 2001 conference being held
             this week (May 11 through 16) in Chicago.

      Why:     Physicians at the University of Illinois at Chicago
             Medical Center will soon begin injecting pancreatic islet
             cells through the portal vein directly into the liver of
             Type 1 diabetes patients. This procedure may eliminate
             the need for insulin and the long-term complications of
             diabetes for millions of people.

      Where:   University of Illinois at Chicago Medical Center,
             Molecular Biology Research Building Auditorium, First
             Floor, 900 South Marshfield Avenue, Chicago, IL 60612.

      Contact: Call Lauren Mistretta, Ogilvy Public Relations Worldwide,
             312-397-6017, lauren.mistretta@ogilvypr.com for more
             information or to arrange transportation to this special
             event.
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 15, 2001
Words:297
Previous Article:Aether Systems Signs Wireless Mobile Data Contracts With Sheriffs Offices in Oklahoma and Tennessee.
Next Article:Texar and ShareThis Form Partnership To Extend Joint Sales and Marketing Efforts.



Related Articles
Gene test foretells Type I diabetes risk.
Novel diabetes strain has rapid onset.(Brief Article)
Transplanted Hopes.(pancreatic islet transplants may help diabetics)
MiniMed Investments Strengthen Market Advantage.(Brief Article)
SHE'S WALKING THE WALK, TALKING THE TALK; SPUNKY 3RD-GRADER OUT FRONT IN FIGHT AGAINST DIABETES.(L.A. Life)
Use the Net to streamline medical research.
Health care issues as the child with chronic illness transitions to adulthood. (Editorial).(Editorial)
CHECKUP LIVER CELLS REBORN AS INSULIN PRODUCERS.(U)
The patient's page.(Special Section)
A growing problem: diabetes and obesity are taking a toll on the U.S. health-care system. Health insurers and disability carriers are reaching out to...

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles